PT1459748E - (s,s)-reboxetina para tratar a neuropatia periferica - Google Patents

(s,s)-reboxetina para tratar a neuropatia periferica

Info

Publication number: PT1459748E
Authority: PT; Portugal
Prior art keywords: reboxetine; peripheral neuropathy; treating peripheral; treating; neuropathy
Prior art date: 1999-07-01

Application number

PT04013379T

Other languages

English (en)

Inventor

Saeeduddin Ahmed

Lars Birgerson

Pasquale Cetera

Robert Clyde Marshall

Robert Mcarthur

Duncan P Taylor

Erik H F Wong

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-01

Filing date

2000-06-22

Publication date

2005-08-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27495506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1459748(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-06-22 Application filed by Upjohn Co filed Critical Upjohn Co

2005-08-31 Publication of PT1459748E publication Critical patent/PT1459748E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Obesity (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Nutrition Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Anesthesiology (AREA)
Child & Adolescent Psychology (AREA)
Pulmonology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Physical Education & Sports Medicine (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PT04013379T 1999-07-01 2000-06-22 (s,s)-reboxetina para tratar a neuropatia periferica PT1459748E (pt)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US14196899P	1999-07-01	1999-07-01
US14413199P	1999-07-16	1999-07-16
US15825699P	1999-10-06	1999-10-06
US17038199P	1999-12-13	1999-12-13

Publications (1)

Publication Number	Publication Date
PT1459748E true PT1459748E (pt)	2005-08-31

Family

ID=27495506

Family Applications (5)

Application Number	Title	Priority Date	Filing Date
PT00941659T PT1196172E (pt)	1999-07-01	2000-06-22	(s,s)-reboxetina para tratar a dor cronica
PT04013383T PT1459751E (pt)	1999-07-01	2000-06-22	(s,s)-reboxetina para tratar as enxaquecas
PT05111704T PT1632234E (pt)	1999-07-01	2000-06-22	(s,s)-reboxetina para o tratamento da síndrome de fadiga crónica
PT04013379T PT1459748E (pt)	1999-07-01	2000-06-22	(s,s)-reboxetina para tratar a neuropatia periferica
PT04013382T PT1459750E (pt)	1999-07-01	2000-06-22	(s,s)- reboxetina para tratar a fibromialgia ou outras perturbacoes somatoformes

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
PT00941659T PT1196172E (pt)	1999-07-01	2000-06-22	(s,s)-reboxetina para tratar a dor cronica
PT04013383T PT1459751E (pt)	1999-07-01	2000-06-22	(s,s)-reboxetina para tratar as enxaquecas
PT05111704T PT1632234E (pt)	1999-07-01	2000-06-22	(s,s)-reboxetina para o tratamento da síndrome de fadiga crónica

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PT04013382T PT1459750E (pt)	1999-07-01	2000-06-22	(s,s)- reboxetina para tratar a fibromialgia ou outras perturbacoes somatoformes

Country Status (30)

Country	Link
US (18)	US6465458B1 (pt)
EP (3)	EP1196172B1 (pt)
JP (3)	JP2003503450A (pt)
KR (5)	KR100948757B1 (pt)
CN (5)	CN1660108A (pt)
AR (1)	AR035158A1 (pt)
AT (9)	ATE296634T1 (pt)
AU (2)	AU771258B2 (pt)
BR (1)	BR0012136A (pt)
CA (2)	CA2643231A1 (pt)
CL (3)	CL2008002866A1 (pt)
CO (1)	CO5190662A1 (pt)
CZ (1)	CZ299847B6 (pt)
DE (9)	DE60026627T2 (pt)
DK (4)	DK1196172T3 (pt)
EA (6)	EA011094B1 (pt)
ES (9)	ES2258010T3 (pt)
GE (1)	GEP20094798B (pt)
HU (1)	HUP0201623A3 (pt)
IL (3)	IL147246A0 (pt)
MX (1)	MXPA02000562A (pt)
MY (1)	MY137348A (pt)
NO (4)	NO20016406L (pt)
NZ (2)	NZ533243A (pt)
PE (1)	PE20010684A1 (pt)
PL (1)	PL196996B1 (pt)
PT (5)	PT1196172E (pt)
SK (5)	SK286668B6 (pt)
TW (9)	TW200407146A (pt)
WO (1)	WO2001001973A2 (pt)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001001973A2 (en) *	1999-07-01	2001-01-11	Pharmacia & Upjohn Company	Highly selective norepinephrine reuptake inhibitors and methods of using the same
RO121085B1 (ro) *	1999-12-01	2006-12-29	Ucb, S.A.,	Utilizarea levetiracetamului, în tratamentul bolilor sistemului nervos central
CN1554341A (zh)	2000-04-21	2004-12-15	��Ŷ��Լ��˾	用于治疗纤维肌痛和慢性疲劳综合症的化合物
NZ522115A (en) *	2000-04-21	2004-07-30	Upjohn Co	Selected compounds for the treatment of fibromyalgia and chronic fatigue syndrome
EP1333835A1 (en) *	2000-10-31	2003-08-13	Head Explorer A/S	The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache
EP1395253A2 (en) *	2000-11-15	2004-03-10	Eli Lilly And Company	Treatment of anxiety disorders
WO2002083141A1 (en) *	2001-04-17	2002-10-24	Pharmacia & Upjohn Company	Treatment of fibromyalgia and chronic fatigue syndrome
GB0216027D0 (en) *	2002-07-10	2002-08-21	Arachnova Therapeutics Ltd	New therapeutic use
US20040048874A1 (en) *	2001-05-22	2004-03-11	Bardsley Hazel Judith	New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
US20060167074A1 (en) *	2001-06-19	2006-07-27	Norbert Muller	Methods and compositions for the treatment of psychiatric disorders
WO2002102297A2 (en) *	2001-06-19	2002-12-27	Mueller Norbert	Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders
US6602911B2 (en) *	2001-11-05	2003-08-05	Cypress Bioscience, Inc.	Methods of treating fibromyalgia
ATE365035T1 (de) *	2001-11-30	2007-07-15	Lilly Co Eli	Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks
EP1458368B1 (en) *	2001-12-11	2007-11-21	Eli Lilly And Company	Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
US20040102440A1 (en) *	2002-07-01	2004-05-27	Wong Erik Ho Fong	Method of promoting smoking cessation
EP1482921A1 (en) *	2002-02-12	2004-12-08	Cypress Bioscience, Inc.	Methods of treating attention deficit/hyperactivity disorder (adhd)
CA2483093A1 (en) *	2002-04-24	2003-11-06	Cypress Bioscience, Inc.	Use of milnacipran or a pharmaceutically acceptable salt thereof for treating chronic low back pain
RU2341259C2 (ru) *	2002-05-17	2008-12-20	Дюк Юниверсити	Способ лечения ожирения
DK1513529T3 (da) *	2002-05-30	2012-03-26	Neurosearch As	Tredobbelte monoamin-genoptagelsesinhibitorer til behandling af kronisk smerte
MXPA04011916A (es) *	2002-06-17	2005-03-31	Pharmacia Italia Spa	Sales farmaceuticas de reboxetina.
US20070196481A1 (en) *	2002-07-25	2007-08-23	Amidon Gregory E	Sustained-release tablet composition
US20050226926A1 (en)	2002-07-25	2005-10-13	Pfizer Inc	Sustained-release tablet composition of pramipexole
KR20050049476A (ko) *	2002-08-14	2005-05-25	파마시아 앤드 업존 캄파니 엘엘씨	홍조를 치료하기 위한 레복세틴의 용도
GB0219687D0 (en)	2002-08-23	2002-10-02	Lilly Co Eli	Benzyl morpholine derivatives
ATE327982T1 (de) *	2002-08-23	2006-06-15	Lilly Co Eli	Benzylmorpholinderivate
DE60324685D1 (de)	2002-08-23	2008-12-24	Lilly Co Eli	2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin-wiederaufnahme-inhibitoren
AU2003284005B2 (en) *	2002-10-03	2009-12-17	Forest Laboratories Holdings Limited	Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
US7345096B2 (en) *	2002-10-15	2008-03-18	Wyeth	Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US20040152710A1 (en) *	2002-10-15	2004-08-05	Deecher Darlene Coleman	Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US20040180879A1 (en) *	2002-10-15	2004-09-16	Deecher Darlene Coleman	Novel method of treating vasomotor symptoms
US20040204411A1 (en) *	2002-12-17	2004-10-14	Pharmacia Corporation	Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
JP2006516977A (ja) *	2003-01-13	2006-07-13	ダイノゲンファーマシューティカルズ，インコーポレイテッド	悪心、嘔吐、レッチング、またはそれらの任意の組み合わせの治療方法
NZ541008A (en) *	2003-01-13	2007-09-28	Dynogen Pharmaceuticals Inc	Method of treating functional bowel disorders
EP1539181B1 (en) *	2003-04-04	2007-06-27	Dynogen Pharmaceuticals Inc.	Method of treating lower urinary tract disorders
PT2316456T (pt)	2003-04-29	2017-09-05	Orexigen Therapeutics Inc	Composições para afetar a perda de peso compreendendo naltrexona e bupropion
US8158149B2 (en) *	2004-05-12	2012-04-17	Chelsea Therapeutics, Inc.	Threo-DOPS controlled release formulation
WO2004100929A1 (en)	2003-05-12	2004-11-25	Synergia Pharma, Inc.	Threo-dops controlled release formulation
WO2004105690A2 (en) *	2003-05-23	2004-12-09	Cypress Bioscience, Inc.	Treatment of chronic pain associated with drug or radiation therapy
GB0319793D0 (en)	2003-08-22	2003-09-24	Lilly Co Eli	Pyridinylmorpholine derivatives
WO2005020976A2 (en) *	2003-08-27	2005-03-10	Eli Lilly And Company	Treatment of pervasive developmental disorders with norepinephrine reuptake inhibitors
US20070010584A1 (en) *	2003-09-04	2007-01-11	Peroutka Stephen J	Compositions and methods for orthostatic intolerance
AU2004271800A1 (en) *	2003-09-12	2005-03-24	Pfizer Inc.	Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
US7419980B2 (en)	2003-10-14	2008-09-02	Wyeth	Fused-aryl and heteroaryl derivatives and methods of their use
US7491723B2 (en)	2003-10-14	2009-02-17	Wyeth	Alkanol and cycloalkanol-amine derivatives and methods of their use
US7365076B2 (en)	2003-10-14	2008-04-29	Wyeth	Substituted aryl cycloalkanol derivatives and methods of their use
US7524846B2 (en)	2003-10-14	2009-04-28	Wyeth	Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US20050130987A1 (en) *	2003-10-14	2005-06-16	Wyeth	Methods of treating vasomotor symptoms
US7402698B2 (en)	2003-10-14	2008-07-22	Wyeth	Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7550485B2 (en)	2003-10-14	2009-06-23	Wyeth	Substituted N-heterocycle derivatives and methods of their use
US7531543B2 (en)	2003-10-14	2009-05-12	Wyeth	Phenylpiperazine cycloalkanol derivatives and methods of their use
GB0326148D0 (en) *	2003-11-10	2003-12-17	Lilly Co Eli	Morpholine derivatives
KR20060121178A (ko) *	2003-12-12	2006-11-28	일라이 릴리 앤드 캄파니	일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제
ATE423772T1 (de)	2003-12-23	2009-03-15	Lilly Co Eli	Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin
US7517899B2 (en) *	2004-03-30	2009-04-14	Wyeth	Phenylaminopropanol derivatives and methods of their use
US7414052B2 (en)	2004-03-30	2008-08-19	Wyeth	Phenylaminopropanol derivatives and methods of their use
KR100871272B1 (ko) *	2004-04-30	2008-11-28	화이자 인코포레이티드	모폴린 화합물
GB0409744D0 (en) *	2004-04-30	2004-06-09	Pfizer Ltd	Novel compounds
EA200601798A1 (ru) *	2004-04-30	2007-04-27	Уорнер-Ламберт Компани Ллс	Замещенные соединения морфолина для лечения расстройств центральной нервной системы
US20080261984A1 (en) *	2004-06-09	2008-10-23	Pfizer Inc.	Use of S,S-Reboxetine in the Treatment of Pain
US7244765B2 (en) *	2004-06-25	2007-07-17	Cytokine Pharmasciences, Inc	Guanylhydrazone salts, compositions, processes of making and methods of using
US20090227562A1 (en) *	2004-08-10	2009-09-10	Pfizer Inc.	Combination of a Selective Noradrenaline Reuptake Unhibitor and a PDEV Inhibitor
KR101052436B1 (ko)	2004-08-13	2011-07-29	베링거 인겔하임 인터내셔날 게엠베하	프라미펙솔 또는 약제학적으로 허용되는 이의 염을함유하는 연장 방출형 정제 제형, 이의 제조방법 및 이의용도
AU2005290980A1 (en) *	2004-10-01	2006-04-13	Neurocure Ltd	Use of pharmaceutical compositions of lofepramine for the treatment of ADHD, CFS, FM and depression
US20060293309A1 (en) *	2005-03-28	2006-12-28	Dynogen Pharmaceuticals, Inc.	Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
US7994220B2 (en) *	2005-09-28	2011-08-09	Cypress Bioscience, Inc.	Milnacipran for the long-term treatment of fibromyalgia syndrome
CN101370488B (zh)	2005-11-22	2012-07-18	奥雷西根治疗公司	增加胰岛素敏感性的组合物
US20070253994A1 (en) *	2006-04-28	2007-11-01	Medtronic, Inc.	Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain
US8916195B2 (en)	2006-06-05	2014-12-23	Orexigen Therapeutics, Inc.	Sustained release formulation of naltrexone
US20080015181A1 (en) *	2006-06-28	2008-01-17	Chelsea Therapeutics, Inc.	Pharmaceutical Compositions Comprising Droxidopa
US20080110792A1 (en)	2006-11-09	2008-05-15	Orexigen Therapeutics, Inc.	Methods for administering weight loss medications
JP2010520885A (ja)	2007-03-09	2010-06-17	チェルシー・セラピューティクス，インコーポレイテッド	線維筋痛症の治療のためのドロキシドパ及びその医薬組成物
WO2008122019A1 (en) *	2007-04-02	2008-10-09	Cypress Biosciences, Inc.	Improving the tolerability of both mirtazapine and reboxetine by using them in combination
MX2009011858A (es) *	2007-04-30	2010-01-14	Adolor Corp	Composiciones de (-)-e-10-oh-nt y metodos para su sintesis y uso.
JP2010526820A (ja) *	2007-05-07	2010-08-05	チェルシー・セラピューティクス，インコーポレイテッド	気分障害、睡眠障害、または注意欠陥障害を治療するドロキシドパおよびその医薬組成物
US8580776B2 (en) *	2007-07-10	2013-11-12	The Board Of Trustees Of The University Of Illinois	Compositions and methods for treating neurodegenerating diseases
US20090233957A1 (en) *	2008-02-19	2009-09-17	Adolor Corporation	(-)-beloxepin and methods for its synthesis and use
US20090233959A1 (en) *	2008-02-19	2009-09-17	Adolor Corporation	Beloxepin and analogs for the treatment of pain
US8940315B2 (en)	2008-04-18	2015-01-27	Medtronic, Inc.	Benzodiazepine formulation in a polyorthoester carrier
US8956642B2 (en)	2008-04-18	2015-02-17	Medtronic, Inc.	Bupivacaine formulation in a polyorthoester carrier
MX2010012909A (es)	2008-05-30	2011-02-25	Orexigen Therapeutics Inc	Metodos para tratamiento de condiciones de grasa visceral.
US7888386B2 (en) *	2008-07-24	2011-02-15	Theravance, Inc.	3-(phenoxyphenylmethyl)pyrrolidine compounds
US20100069389A1 (en) *	2008-09-06	2010-03-18	Bionevia Pharmaceuticals, Inc.	Novel forms of reboxetine
WO2010044016A1 (en) *	2008-10-17	2010-04-22	Pfizer Limited	Novel uses for esreboxetine and racemic reboxetine
WO2010120910A1 (en) *	2009-04-15	2010-10-21	Theravance, Inc.	3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
AU2010273645B2 (en) *	2009-07-13	2014-12-04	Theravance Biopharma R&D Ip, Llc	3-phenoxymethylpyrrolidine compounds
EP2456436B1 (en) *	2009-07-21	2014-06-25	Theravance, Inc.	3-phenoxymethylpyrrolidine compounds
KR101841442B1 (ko)	2010-01-11	2018-03-23	오렉시젠 세러퓨틱스 인크.	주우울증 환자들에 있어서 체중 감량 치료를 제공하는 방법
ES2533434T3 (es)	2010-10-11	2015-04-10	Theravance Biopharma R&D Ip, Llc	Inhibidores de la captación de la serotonina
US8501964B2 (en)	2010-12-03	2013-08-06	Theravance, Inc.	Serotonin reuptake inhibitors
JP5880913B2 (ja)	2011-05-17	2016-03-09	三郎佐古田	パーキンソン病の体幹症状（姿勢反射異常）の治療剤
IL300868A (en)	2012-06-06	2023-04-01	Orexigen Therapeutics Inc	Methods for treating overweight and obesity
WO2016077724A1 (en)	2014-11-13	2016-05-19	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	(2-amino-4(arylamino)phenyl) carbamates
US20190381056A1 (en)	2018-06-17	2019-12-19	Axsome Therapeutics, Inc.	Compositions for delivery of reboxetine
WO2021113163A1 (en) *	2019-12-03	2021-06-10	Axsome Therapeutics, Inc.	Use of reboxetine to treat nervous system disorders
US20200147093A1 (en)	2018-10-15	2020-05-14	Axsome Therapeutics, Inc.	Use of esreboxetine to treat nervous system disorders such as fibromyalgia
US11020402B2 (en)	2018-10-15	2021-06-01	Axsome Therapeutics, Inc.	Use of reboxetine to treat narcolepsy
EP3693020A1 (en) *	2019-02-08	2020-08-12	Burmaster International Group GmbH	Potassium enriched topical formulations for pain relief and sleep aid
MX2022006630A (es) *	2019-12-03	2022-06-24	Axsome Therapeutics Inc	Uso de reboxetina para tratar los trastornos del sistema nervioso.

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3797494A (en)	1969-04-01	1974-03-19	Alza Corp	Bandage for the administration of drug by controlled metering through microporous materials
US3742951A (en)	1971-08-09	1973-07-03	Alza Corp	Bandage for controlled release of vasodilators
US3996934A (en)	1971-08-09	1976-12-14	Alza Corporation	Medical bandage
US4031894A (en)	1975-12-08	1977-06-28	Alza Corporation	Bandage for transdermally administering scopolamine to prevent nausea
IL56369A (en)	1978-01-20	1984-05-31	Erba Farmitalia	Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
US4465458A (en) *	1980-03-19	1984-08-14	Matsushita Electric Industrial Co., Ltd.	Apparatus for burning liquid fuel equipped with heating-type fuel vaporizer
GB8419683D0 (en)	1984-08-02	1984-09-05	Erba Farmitalia	3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en) *	1984-11-22	1988-05-11	Erba Farmitalia	Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
US4596807A (en)	1985-03-26	1986-06-24	Serotonin Industries Of Charleston	Method and compositions for controlling pain, depression and sedation
US5023252A (en)	1985-12-04	1991-06-11	Conrex Pharmaceutical Corporation	Transdermal and trans-membrane delivery of drugs
US5011472A (en)	1988-09-06	1991-04-30	Brown University Research Foundation	Implantable delivery system for biological factors
ZA921292B (en)	1991-02-25	1993-08-23	Lilly Co Eli	Treatment of lower urinary tract disorders.
US5281624A (en)	1991-09-27	1994-01-25	Eli Lilly And Company	N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
US5192751A (en)	1992-07-24	1993-03-09	Eli Lilly And Company	Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence
TW344661B (en)	1993-11-24	1998-11-11	Lilly Co Eli	Pharmaceutical composition for treatment of incontinence
IL111786A0 (en)	1993-12-01	1995-01-24	Max Planck Gesellschaft	Methods of promoting the survival and differentiation of subclasses of cholinergic and serotonergic neurons using fibroblast growth factor-5
CA2134038C (en) *	1994-06-16	1997-06-03	David Taiwai Wong	Potentiation of drug response
ZA958725B (en)	1994-10-20	1997-04-16	Lilly Co Eli	Treatment of disorders with duloxetine
CA2250042A1 (en)	1996-03-25	1997-10-02	Eli Lilly And Company	Treating pain using a synergistic combination of an atypical antipsychotic and a drug used in treatment of pain
CN1494907A (zh)	1996-03-25	2004-05-12		治疗疼痛的药物组合物
US5914333A (en) *	1996-07-31	1999-06-22	Novo Nordisk A/S	Treatment of psychotic disorders
US20020015713A1 (en) *	1996-10-24	2002-02-07	Murdock Robert W.	Methods and transdermal compositions for pain relief
US6290986B1 (en) *	1996-10-24	2001-09-18	Pharmaceutical Applications Associates, Llc	Method and composition for transdermal administration of pharmacologic agents
US6479074B2 (en) *	1996-10-24	2002-11-12	Pharmaceutical Applications Associates Llc	Methods and transdermal compositions for pain relief
US6572880B2 (en) *	1996-10-24	2003-06-03	Pharmaceutical Applications Associates Llc	Methods and transdermal compositions for pain relief
ES2125696T3 (es)	1996-11-27	1999-03-01	Pfleger R Chem Fab	Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales.
KR20000057548A (ko)	1996-12-13	2000-09-25	알프레드 엘. 미첼슨	광학적 전송물질 및 결합재
AU6966998A (en)	1997-04-11	1998-11-11	Eli Lilly And Company	Composition for treating pain
US5942530A (en)	1997-08-28	1999-08-24	Eli Lilly And Company	Method for treating pain
AU5155198A (en)	1997-08-28	1999-03-22	Robert Murdock	Method and composition for transdermal administration of pharmacologic agent
US6622036B1 (en) *	2000-02-09	2003-09-16	Cns Response	Method for classifying and treating physiologic brain imbalances using quantitative EEG
UA57107C2 (uk) *	1997-09-23	2003-06-16	Елі Ліллі Енд Компані	Спосіб лікування розладу поведінки
UA56257C2 (uk) *	1997-09-23	2003-05-15	Елі Ліллі Енд Компані	Спосіб лікування неадекватної визивної поведінки
JP2001517628A (ja) *	1997-09-23	2001-10-09	イーライ・リリー・アンド・カンパニー	注意欠陥／多動障害の治療法
CA2306233A1 (en)	1997-10-17	1999-04-29	Eli Lilly And Company	Potentiation of pharmaceuticals
US6586427B2 (en) *	1998-04-09	2003-07-01	Pharmacia & Upjohn Company	Treatments for nervous disorders
DK1069900T3 (da) *	1998-04-09	2005-10-31	Pharmacia & Upjohn Co Llc	Anvendelse af reboxetin til behandling af neuropsykiatriske lidelser
IT1305322B1 (it)	1998-04-23	2001-05-04	Pharmacia & Upjohn Spa	Uso di reboxetina per il trattamento di disturbi nervosi
SI1075264T1 (en) *	1998-05-08	2005-06-30	Pharmacia & Upjohn Company	New drug combinations of reboxetine and pindolol
IL140420A0 (en)	1998-06-29	2002-02-10	Pharmaceuticals Applic Associa	Methods and transdermal compositions for pain relief
US6331571B1 (en) *	1998-08-24	2001-12-18	Sepracor, Inc.	Methods of treating and preventing attention deficit disorders
WO2001001973A2 (en) *	1999-07-01	2001-01-11	Pharmacia & Upjohn Company	Highly selective norepinephrine reuptake inhibitors and methods of using the same
GB2355191A (en) *	1999-10-12	2001-04-18	Laxdale Ltd	Combination formulations for fatigue, head injury and strokes
SE9904750D0 (sv)	1999-12-23	1999-12-23	Pharmacia & Upjohn Ab	New formulation, use and method
CN1396829A (zh)	2000-02-24	2003-02-12	法玛西雅厄普约翰美国公司	新的药物联合形式
US20050096349A1 (en) *	2003-11-03	2005-05-05	University Of Florida	Methods to prevent or ameliorate medication-, procedure-or stress-induced cognitive and speech dysfunction and methods to optimize cognitive and speech functioning

2000
- 2000-06-22 WO PCT/US2000/017256 patent/WO2001001973A2/en not_active Ceased
- 2000-06-22 KR KR1020097015713A patent/KR100948757B1/ko not_active Expired - Fee Related
- 2000-06-22 ES ES00941659T patent/ES2258010T3/es not_active Expired - Lifetime
- 2000-06-22 AU AU56337/00A patent/AU771258B2/en not_active Ceased
- 2000-06-22 DE DE60026627T patent/DE60026627T2/de not_active Expired - Fee Related
- 2000-06-22 EP EP00941659A patent/EP1196172B1/en not_active Expired - Lifetime
- 2000-06-22 SK SK50023-2007A patent/SK286668B6/sk not_active IP Right Cessation
- 2000-06-22 EA EA200700232A patent/EA011094B1/ru not_active IP Right Cessation
- 2000-06-22 AT AT04013382T patent/ATE296634T1/de not_active IP Right Cessation
- 2000-06-22 BR BR0012136-3A patent/BR0012136A/pt not_active Application Discontinuation
- 2000-06-22 CN CN2004101045222A patent/CN1660108A/zh active Pending
- 2000-06-22 PT PT00941659T patent/PT1196172E/pt unknown
- 2000-06-22 CN CN2004101045237A patent/CN1660109A/zh active Pending
- 2000-06-22 DE DE60022916T patent/DE60022916T2/de not_active Expired - Fee Related
- 2000-06-22 GE GEAP200011110A patent/GEP20094798B/en unknown
- 2000-06-22 KR KR1020017016963A patent/KR100704319B1/ko not_active Expired - Fee Related
- 2000-06-22 PT PT04013383T patent/PT1459751E/pt unknown
- 2000-06-22 EP EP09161068A patent/EP2090312A1/en not_active Withdrawn
- 2000-06-22 PL PL352252A patent/PL196996B1/pl not_active IP Right Cessation
- 2000-06-22 ES ES04025513T patent/ES2258251T3/es not_active Expired - Lifetime
- 2000-06-22 AT AT04023888T patent/ATE305306T1/de not_active IP Right Cessation
- 2000-06-22 IL IL14724600A patent/IL147246A0/xx not_active IP Right Cessation
- 2000-06-22 DE DE60022917T patent/DE60022917T2/de not_active Expired - Fee Related
- 2000-06-22 NZ NZ533243A patent/NZ533243A/en unknown
- 2000-06-22 DE DE60022692T patent/DE60022692T2/de not_active Expired - Lifetime
- 2000-06-22 AT AT05111704T patent/ATE364386T1/de not_active IP Right Cessation
- 2000-06-22 SK SK50022-2007A patent/SK286864B6/sk not_active IP Right Cessation
- 2000-06-22 AT AT00941659T patent/ATE320257T1/de not_active IP Right Cessation
- 2000-06-22 DK DK00941659T patent/DK1196172T3/da active
- 2000-06-22 ES ES04013383T patent/ES2247572T3/es not_active Expired - Lifetime
- 2000-06-22 SK SK1938-2001A patent/SK286104B6/sk not_active IP Right Cessation
- 2000-06-22 US US09/599,213 patent/US6465458B1/en not_active Expired - Lifetime
- 2000-06-22 AT AT04013379T patent/ATE292971T1/de not_active IP Right Cessation
- 2000-06-22 ES ES04013381T patent/ES2246485T3/es not_active Expired - Lifetime
- 2000-06-22 DE DE60035232T patent/DE60035232T2/de not_active Expired - Lifetime
- 2000-06-22 DE DE60020613T patent/DE60020613T2/de not_active Expired - Lifetime
- 2000-06-22 CA CA002643231A patent/CA2643231A1/en not_active Abandoned
- 2000-06-22 ES ES04023888T patent/ES2246487T3/es not_active Expired - Lifetime
- 2000-06-22 DE DE60019473T patent/DE60019473T2/de not_active Expired - Lifetime
- 2000-06-22 SK SK50021-2007A patent/SK286667B6/sk not_active IP Right Cessation
- 2000-06-22 AT AT04013381T patent/ATE305788T1/de not_active IP Right Cessation
- 2000-06-22 KR KR1020067017835A patent/KR100935277B1/ko not_active Expired - Fee Related
- 2000-06-22 AT AT04025514T patent/ATE305307T1/de not_active IP Right Cessation
- 2000-06-22 AT AT04013383T patent/ATE304358T1/de not_active IP Right Cessation
- 2000-06-22 EA EA200400589A patent/EA006652B1/ru not_active IP Right Cessation
- 2000-06-22 PT PT05111704T patent/PT1632234E/pt unknown
- 2000-06-22 ES ES04013382T patent/ES2242175T3/es not_active Expired - Lifetime
- 2000-06-22 CZ CZ20014625A patent/CZ299847B6/cs not_active IP Right Cessation
- 2000-06-22 JP JP2001507467A patent/JP2003503450A/ja active Pending
- 2000-06-22 NZ NZ515885A patent/NZ515885A/en unknown
- 2000-06-22 ES ES05111704T patent/ES2285645T3/es not_active Expired - Lifetime
- 2000-06-22 CA CA002375908A patent/CA2375908C/en not_active Expired - Fee Related
- 2000-06-22 KR KR1020057009371A patent/KR100717660B1/ko not_active Expired - Fee Related
- 2000-06-22 CN CN2004101045241A patent/CN1660110A/zh active Pending
- 2000-06-22 KR KR1020097015714A patent/KR20090087135A/ko not_active Ceased
- 2000-06-22 PT PT04013379T patent/PT1459748E/pt unknown
- 2000-06-22 CN CNB2004101045256A patent/CN1289090C/zh not_active Expired - Fee Related
- 2000-06-22 EA EA200801806A patent/EA200801806A1/ru unknown
- 2000-06-22 EA EA200501496A patent/EA008381B1/ru not_active IP Right Cessation
- 2000-06-22 MX MXPA02000562A patent/MXPA02000562A/es active IP Right Grant
- 2000-06-22 PT PT04013382T patent/PT1459750E/pt unknown
- 2000-06-22 AT AT04025513T patent/ATE319453T1/de not_active IP Right Cessation
- 2000-06-22 SK SK50024-2007A patent/SK286669B6/sk not_active IP Right Cessation
- 2000-06-22 ES ES04013379T patent/ES2239311T3/es not_active Expired - Lifetime
- 2000-06-22 EP EP09161069A patent/EP2087892A3/en not_active Withdrawn
- 2000-06-22 DE DE60023043T patent/DE60023043T2/de not_active Expired - Lifetime
- 2000-06-22 ES ES04025514T patent/ES2246488T3/es not_active Expired - Lifetime
- 2000-06-22 DE DE60026704T patent/DE60026704T2/de not_active Expired - Lifetime
- 2000-06-22 DK DK04013381T patent/DK1459749T3/da active
- 2000-06-22 CN CNB008084858A patent/CN1205935C/zh not_active Expired - Fee Related
- 2000-06-22 DK DK04013382T patent/DK1459750T3/da active
- 2000-06-22 HU HU0201623A patent/HUP0201623A3/hu unknown
- 2000-06-22 EA EA200801805A patent/EA200801805A1/ru unknown
- 2000-06-22 DK DK05111704T patent/DK1632234T3/da active
- 2000-06-22 EA EA200200111A patent/EA005029B1/ru not_active IP Right Cessation
- 2000-06-27 MY MYPI20002899A patent/MY137348A/en unknown
- 2000-06-28 PE PE2000000664A patent/PE20010684A1/es not_active Application Discontinuation
- 2000-06-30 AR ARP000103350A patent/AR035158A1/es unknown
- 2000-07-04 CO CO00049691A patent/CO5190662A1/es not_active Application Discontinuation
- 2000-09-05 TW TW092137686A patent/TW200407146A/zh unknown
- 2000-09-05 TW TW097124426A patent/TW200914027A/zh unknown
- 2000-09-05 TW TW089113086A patent/TWI245631B/zh not_active IP Right Cessation
- 2000-09-05 TW TW097124457A patent/TW200920378A/zh unknown
- 2000-09-05 TW TW094142126A patent/TWI298254B/zh not_active IP Right Cessation
- 2000-09-05 TW TW094142131A patent/TWI294779B/zh active
- 2000-09-05 TW TW094142128A patent/TWI298255B/zh not_active IP Right Cessation
- 2000-09-05 TW TW094142132A patent/TWI293250B/zh active
- 2000-09-05 TW TW097124378A patent/TW200922594A/zh unknown
2001
- 2001-12-14 US US10/020,261 patent/US6703389B2/en not_active Expired - Fee Related
- 2001-12-28 NO NO20016406A patent/NO20016406L/no unknown
2002
- 2002-01-04 US US10/037,344 patent/US6610690B2/en not_active Expired - Lifetime
- 2002-01-04 US US10/099,334 patent/US6642235B2/en not_active Expired - Fee Related
- 2002-01-23 US US10/055,663 patent/US6987107B2/en not_active Expired - Fee Related
- 2002-09-26 US US10/255,450 patent/US20030040464A1/en not_active Abandoned
2003
- 2003-09-24 US US10/669,611 patent/US20040058925A1/en not_active Abandoned
2004
- 2004-01-16 US US10/758,864 patent/US7317011B2/en not_active Expired - Fee Related
- 2004-05-18 AU AU2004202096A patent/AU2004202096B2/en not_active Ceased
2006
- 2006-02-07 US US11/349,373 patent/US7276503B2/en not_active Expired - Fee Related
- 2006-02-07 US US11/349,331 patent/US7338953B2/en not_active Expired - Fee Related
- 2006-02-07 US US11/349,022 patent/US7241762B2/en not_active Expired - Fee Related
- 2006-02-07 US US11/348,948 patent/US20060142289A1/en not_active Abandoned
- 2006-02-22 JP JP2006045459A patent/JP2006143749A/ja active Pending
- 2006-07-28 US US11/460,775 patent/US20060264436A1/en not_active Abandoned
- 2006-08-02 JP JP2006210418A patent/JP2006321815A/ja active Pending
2007
- 2007-10-30 US US11/928,980 patent/US20080103147A1/en not_active Abandoned
- 2007-10-30 US US11/928,812 patent/US20080096890A1/en not_active Abandoned
- 2007-10-30 US US11/928,781 patent/US20080103145A1/en not_active Abandoned
- 2007-10-30 US US11/928,917 patent/US7723334B2/en not_active Expired - Fee Related
- 2007-11-20 IL IL187512A patent/IL187512A0/en unknown
- 2007-11-20 IL IL187513A patent/IL187513A0/en unknown
2008
- 2008-09-26 CL CL2008002866A patent/CL2008002866A1/es unknown
- 2008-09-26 CL CL2008002867A patent/CL2008002867A1/es unknown
- 2008-09-26 CL CL2008002868A patent/CL2008002868A1/es unknown
2009
- 2009-03-18 NO NO20091168A patent/NO20091168L/no not_active Application Discontinuation
- 2009-03-18 NO NO20091158A patent/NO20091158L/no unknown
- 2009-03-18 NO NO20091159A patent/NO20091159L/no unknown
- 2009-04-27 US US12/430,244 patent/US20090247528A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PT1196172E (pt)	2006-05-31
SK286864B6 (sk)	2009-06-05
NO20091168L (no)	2002-02-19
AU2004202096B2 (en)	2005-10-20
US20020107249A1 (en)	2002-08-08
WO2001001973A3 (en)	2002-01-17
ATE305307T1 (de)	2005-10-15
WO2001001973A8 (en)	2001-05-17
US20060142289A1 (en)	2006-06-29
EA008381B1 (ru)	2007-04-27
ATE305306T1 (de)	2005-10-15
DE60035232T2 (de)	2008-02-14
PT1632234E (pt)	2007-07-09
US6987107B2 (en)	2006-01-17
US7276503B2 (en)	2007-10-02
PL352252A1 (en)	2003-08-11
TW200914027A (en)	2009-04-01
MY137348A (en)	2009-01-30
KR20090087135A (ko)	2009-08-14
CL2008002868A1 (es)	2009-01-09
DE60020613T2 (de)	2006-03-16
GEP20094798B (en)	2009-10-26
DE60023043T2 (de)	2006-06-14
DE60019473D1 (de)	2005-05-19
ATE296634T1 (de)	2005-06-15
ES2246488T3 (es)	2006-02-16
ATE292971T1 (de)	2005-04-15
CN1660109A (zh)	2005-08-31
DE60026704D1 (de)	2006-05-11
HUP0201623A3 (en)	2004-12-28
IL187512A0 (en)	2008-06-05
US7723334B2 (en)	2010-05-25
KR20020015363A (ko)	2002-02-27
ES2258251T3 (es)	2006-08-16
TWI294779B (en)	2008-03-21
CZ20014625A3 (cs)	2002-08-14
CZ299847B6 (cs)	2008-12-10
TW200607511A (en)	2006-03-01
SK286104B6 (sk)	2008-03-05
US20020061910A1 (en)	2002-05-23
PL196996B1 (pl)	2008-02-29
TWI298255B (en)	2008-07-01
ES2246487T3 (es)	2006-02-16
EP2087892A3 (en)	2009-09-30
US20060135520A1 (en)	2006-06-22
DE60022917D1 (de)	2006-02-09
EP2090312A1 (en)	2009-08-19
KR100948757B1 (ko)	2010-03-23
HK1076723A1 (en)	2006-01-27
ES2246485T3 (es)	2006-02-16
US20040147614A1 (en)	2004-07-29
WO2001001973A2 (en)	2001-01-11
US7317011B2 (en)	2008-01-08
KR20060099544A (ko)	2006-09-19
NZ533243A (en)	2005-12-23
TW200922594A (en)	2009-06-01
DE60023043D1 (de)	2006-02-16
IL147246A0 (en)	2002-08-14
TW200607510A (en)	2006-03-01
DK1459750T3 (da)	2005-08-15
HK1049630A1 (en)	2003-05-23
CN1289090C (zh)	2006-12-13
EA200200111A1 (ru)	2002-06-27
PE20010684A1 (es)	2001-06-24
CL2008002867A1 (es)	2009-01-09
JP2003503450A (ja)	2003-01-28
AU5633700A (en)	2001-01-22
ES2285645T3 (es)	2007-11-16
TW200607512A (en)	2006-03-01
NO20091159L (no)	2002-02-19
DK1459749T3 (da)	2006-01-09
HUP0201623A2 (en)	2002-09-28
DE60026704T2 (de)	2006-10-19
DE60026627D1 (de)	2006-05-04
DK1196172T3 (da)	2006-06-19
EP1196172B1 (en)	2006-03-15
ATE305788T1 (de)	2005-10-15
JP2006321815A (ja)	2006-11-30
DE60022692D1 (de)	2005-10-20
AU771258B2 (en)	2004-03-18
US6465458B1 (en)	2002-10-15
US20060135521A1 (en)	2006-06-22
ES2242175T3 (es)	2005-11-01
US20080096890A1 (en)	2008-04-24
ES2258010T3 (es)	2006-08-16
US7241762B2 (en)	2007-07-10
DE60035232D1 (de)	2007-07-26
ATE304358T1 (de)	2005-09-15
TWI245631B (en)	2005-12-21
NO20091158L (no)	2002-02-19
DE60022692T2 (de)	2006-06-22
TW200920378A (en)	2009-05-16
ATE320257T1 (de)	2006-04-15
BR0012136A (pt)	2002-06-11
CN1660108A (zh)	2005-08-31
CA2375908C (en)	2006-05-30
US6703389B2 (en)	2004-03-09
CL2008002866A1 (es)	2009-01-09
ES2247572T3 (es)	2006-03-01
TW200607509A (en)	2006-03-01
KR100935277B1 (ko)	2010-01-06
MXPA02000562A (es)	2002-07-02
EP2087892A2 (en)	2009-08-12
ES2239311T3 (es)	2005-09-16
PT1459751E (pt)	2005-11-30
ATE364386T1 (de)	2007-07-15
CO5190662A1 (es)	2002-08-29
DK1632234T3 (da)	2007-09-17
EA200801806A1 (ru)	2008-12-30
KR100717660B1 (ko)	2007-05-15
AU2004202096A1 (en)	2004-06-10
SK286667B6 (sk)	2009-03-05
US6642235B2 (en)	2003-11-04
EA200400589A1 (ru)	2004-12-30
US20030040464A1 (en)	2003-02-27
CA2643231A1 (en)	2001-01-11
SK286668B6 (sk)	2009-03-05
KR20050053799A (ko)	2005-06-08
DE60026627T2 (de)	2007-02-01
US20020086864A1 (en)	2002-07-04
US20040058925A1 (en)	2004-03-25
DE60020613D1 (de)	2005-07-07
CN1205935C (zh)	2005-06-15
EA006652B1 (ru)	2006-02-24
JP2006143749A (ja)	2006-06-08
DE60019473T2 (de)	2006-02-23
EA200801805A1 (ru)	2008-12-30
DE60022917T2 (de)	2006-06-29
IL187513A0 (en)	2008-06-05
US20060264436A1 (en)	2006-11-23
US7338953B2 (en)	2008-03-04
EA200501496A1 (ru)	2006-06-30
EA005029B1 (ru)	2004-10-28
TW200407146A (en)	2004-05-16
SK286669B6 (sk)	2009-03-05
US20080103146A1 (en)	2008-05-01
EA011094B1 (ru)	2008-12-30
US20020128173A1 (en)	2002-09-12
US20080103145A1 (en)	2008-05-01
NO20016406L (no)	2002-02-19
CN1660110A (zh)	2005-08-31
CN1379672A (zh)	2002-11-13
TWI293250B (en)	2008-02-11
SK19382001A3 (sk)	2002-07-02
NZ515885A (en)	2004-08-27
CA2375908A1 (en)	2001-01-11
CN1660111A (zh)	2005-08-31
KR20090087134A (ko)	2009-08-14
TWI298254B (en)	2008-07-01
ATE319453T1 (de)	2006-03-15
KR100704319B1 (ko)	2007-04-09
DE60022916D1 (de)	2006-02-09
US20090247528A1 (en)	2009-10-01
EA200700232A1 (ru)	2007-06-29
EP1196172A2 (en)	2002-04-17
AR035158A1 (es)	2004-05-05
NO20016406D0 (no)	2001-12-28
DE60022916T2 (de)	2006-07-06
US20080103147A1 (en)	2008-05-01
US6610690B2 (en)	2003-08-26
PT1459750E (pt)	2005-08-31
US20060128705A1 (en)	2006-06-15

Publication	Publication Date	Title
PT1459748E (pt)	2005-08-31	(s,s)-reboxetina para tratar a neuropatia periferica
BR0008301B1 (pt)	2013-01-22	processo para a fabricaÇço de compostos, e, compostos.
BR0005449B1 (pt)	2008-11-18	aplicador para um tampço.
NL1014915A1 (nl)	2000-10-16	Nieuwe behandelingsmethode.
ID22228A (id)	1999-09-23	Turunan-turunan 16-hidroksi-11-(disubstitusifenil)-estra-4,9-diena
DE60127995D1 (de)	2007-05-31	Viskokupplung für eine korrekturbandrolle
BR9917475B1 (pt)	2013-07-23	processo para a manufatura de compostos, e, modificação do processo.
BR0210309B1 (pt)	2012-05-15	composição para tratamento de roupas a lavar, e, uso da mesma.
ITBO990171A0 (it)	1999-04-15	Macchina depallettizzatrice .
BR0016434B1 (pt)	2011-12-13	método para tratar um tecido.
IT1319526B1 (it)	2003-10-20	Macchina i.s.
ITMO990056A0 (it)	1999-03-25	Troncatrice radiale per profilati.
ES1041429Y (es)	1999-12-01	Escuadradora para premarcos.
DE69929561D1 (de)	2006-04-13	Laufrolle, Herstellungsverfahren
IT1319528B1 (it)	2003-10-20	Macchina i.s.
EP1459748B8 (en)	2005-06-08	(S,S)-reboxetine for treating peripheral neuropathy
MXPA01013317A (es)	2003-10-15	Maquina para cristalizacion.
IT1310733B1 (it)	2002-02-22	Macchina operatrice.
FR2790466B1 (fr)	2011-02-25	Machine i.s.
SI1459748T1 (en)	2005-10-31	(S,S)-reboxetine for treating peripheral neuropathy
ES1030353Y (es)	1996-02-01	Mano para mortero, mejorada.
ITVR20000063A0 (it)	2000-07-03	Macchina utensile.
ES1035751Y (es)	1997-12-01	Maquina para partir aceitunas.
ES1044831Y (es)	2000-11-16	Ruleta para maquinas recreativas.
ES1042443Y (es)	2001-02-16	Maquina para cortar o prensar piezas carnicas.